Company Filing History:
Years Active: 2009-2012
Title: The Innovations of Richard Stead
Introduction
Richard Stead is an accomplished inventor based in Bellevue, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds that target the erythropoietin receptor.
Latest Patents
Richard Stead holds a total of 4 patents. His latest patents focus on erythropoietin receptor peptide formulations and their therapeutic uses. These inventions relate to peptide compounds that act as agonists of the erythropoietin receptor (EPO-R). The inventions also encompass therapeutic methods for treating disorders associated with insufficient or defective red blood cell production. Additionally, pharmaceutical compositions that include these peptide compounds and their dosages are provided.
Career Highlights
Richard Stead is currently associated with Affymax, Inc., where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing therapeutic options for patients with specific blood-related disorders.
Collaborations
Some of Richard's notable coworkers include Anne-Marie Duliege and Kerstin Leuther. Their collaborative efforts contribute to the ongoing research and development in their field.
Conclusion
Richard Stead's innovative work in peptide formulations and therapeutic methods showcases his dedication to improving healthcare solutions. His contributions are vital in addressing critical medical needs related to red blood cell production.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.